Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”
Circulation · 04.08.2026 · 154 (5)
DOI: 10.1161/circulationaha.126.079060 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, erschienen am 04.08.2026. Verfasst von Brian G DeRubertis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, New York Presbyterian-Weill Cornell Medical Center, New York, NY (B.G.D.). Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, New York Presbyterian-Weill Cornell Medical Center, New York, NY (B.G.D.).
- Division of Cardiology, Columbia University Irving Medical Center, New York, NY (S.A.P.).
- Division of Vascular Surgery, The Prince of Wales Hospital and University of New South Wales, Randwick, Australia (R.L.V.).
ORCID-Profile: Brian G DeRubertis, Sahil A Parikh, Ramon L Varcoe
Zitieren
APA
DeRubertis, B. G., Parikh, S. A., Varcoe, R. L., & LIFE-BTK Investigators (2026). Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”. Circulation, 154(5). https://doi.org/10.1161/circulationaha.126.079060
Vancouver
DeRubertis BG, Parikh SA, Varcoe RL, LIFE-BTK Investigators. Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”. Circulation. 2026;154(5). doi:10.1161/circulationaha.126.079060
BibTeX
@article{DeRubertis2026,
author = {DeRubertis, Brian G and Parikh, Sahil A and Varcoe, Ramon L and LIFE-BTK Investigators, LIFE-BTK Investigators},
title = {Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”},
journal = {Circulation},
year = {2026},
volume = {154},
number = {5},
doi = {10.1161/circulationaha.126.079060}
}
EUVIMED